Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
6.22
+0.31 (5.34%)
At close: Aug 21, 2026, 4:00 PM EDT
6.22
0.00 (0.05%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Adial Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-11.51-7.8-8.28-6.89-10.86-17.69
Net Income
-57.8-7.98-13.2-5.12-12.73-19.42
Earnings Per Share
-28.91-11.93-68.01-89.91-317.81-653.06
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
28.715.883.752.8346.06
Total Debt
-----0.26
Net Cash (Debt)
28.715.883.752.8345.81
Net Cash Growth
385.41%56.81%32.66%-29.35%-31.07%31.90%
Net Cash Per Share
14.368.8019.3349.6199.90195.19

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.13-6.49-6.92-6.81-11.19-11.95
Capital Expenditures
------0.06
Free Cash Flow
-11.13-6.49-6.92-6.81-11.19-12.01
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.